Literature DB >> 28332502

Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer.

Rodrigo Dienstmann, Louis Vermeulen, Justin Guinney, Scott Kopetz, Sabine Tejpar, Josep Tabernero.   

Abstract

Entities:  

Year:  2017        PMID: 28332502     DOI: 10.1038/nrc.2017.24

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

Review 1.  Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer.

Authors:  Rodrigo Dienstmann; Louis Vermeulen; Justin Guinney; Scott Kopetz; Sabine Tejpar; Josep Tabernero
Journal:  Nat Rev Cancer       Date:  2017-01-04       Impact factor: 60.716

  1 in total
  55 in total

Review 1.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

2.  Consensus Molecular Subtypes of Colorectal Cancer and their Clinical Implications.

Authors:  Ketan Thanki; Michael E Nicholls; Aakash Gajjar; Anthony J Senagore; Suimin Qiu; Csaba Szabo; Mark R Hellmich; Celia Chao
Journal:  Int Biol Biomed J       Date:  2017-06-13

Review 3.  Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?

Authors:  Juhong Yang; Reiko Nishihara; Xuehong Zhang; Shuji Ogino; Zhi Rong Qian
Journal:  J Diabetes Complications       Date:  2017-04-13       Impact factor: 2.852

4.  Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis.

Authors:  Zhujiang Dai; Xiang Peng; Yuegui Guo; Xia Shen; Wenjun Ding; Jihong Fu; Zhonglin Liang; Jinglue Song
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-22       Impact factor: 4.553

Review 5.  Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.

Authors:  Shailja C Shah; Steven H Itzkowitz
Journal:  Gastroenterology       Date:  2021-10-29       Impact factor: 22.682

6.  Risk Factor Profiles Differ for Cancers of Different Regions of the Colorectum.

Authors:  Liang Wang; Chun-Han Lo; Xiaosheng He; Dong Hang; Molin Wang; Kana Wu; Andrew T Chan; Shuji Ogino; Edward L Giovannucci; Mingyang Song
Journal:  Gastroenterology       Date:  2020-04-01       Impact factor: 22.682

Review 7.  Back to the Colorectal Cancer Consensus Molecular Subtype Future.

Authors:  David G Menter; Jennifer S Davis; Bradley M Broom; Michael J Overman; Jeffrey Morris; Scott Kopetz
Journal:  Curr Gastroenterol Rep       Date:  2019-01-30

8.  Precancer Atlas to Drive Precision Prevention Trials.

Authors:  Avrum Spira; Matthew B Yurgelun; Ludmil Alexandrov; Anjana Rao; Rafael Bejar; Kornelia Polyak; Marios Giannakis; Ali Shilatifard; Olivera J Finn; Madhav Dhodapkar; Neil E Kay; Esteban Braggio; Eduardo Vilar; Sarah A Mazzilli; Timothy R Rebbeck; Judy E Garber; Victor E Velculescu; Mary L Disis; Douglas C Wallace; Scott M Lippman
Journal:  Cancer Res       Date:  2017-04-01       Impact factor: 13.312

9.  Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype.

Authors:  Alexandre Ghazi; Delphine Le Corre; Camilla Pilati; Julien Taieb; Thomas Aparicio; Audrey Didelot; Shoukat Dedhar; Claire Mulot; Karine Le Malicot; Fatima Djouadi; Aurélien de Reynies; Jean-Marie Launay; Pierre Laurent-Puig; Sophie Mouillet-Richard
Journal:  Oncoimmunology       Date:  2021-06-28       Impact factor: 8.110

10.  Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53.

Authors:  Patrizia Malkomes; Ilaria Lunger; Elsie Oppermann; Khalil Abou-El-Ardat; Thomas Oellerich; Stefan Günther; Can Canbulat; Sabrina Bothur; Frank Schnütgen; Weijia Yu; Susanne Wingert; Nadine Haetscher; Claudia Catapano; Marina S Dietz; Mike Heilemann; Hans-Michael Kvasnicka; Katharina Holzer; Hubert Serve; Wolf Otto Bechstein; Michael A Rieger
Journal:  Oncogene       Date:  2021-06-08       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.